Reaction
Eastern Cooperative Oncology Group Performance Status reporting signals
As of the last recalculation, Eastern Cooperative Oncology Group Performance Status appears in 92 FAERS reports alongside 2 co-occurring drug terms. The strongest observed disproportionality signal is NIRAPARIB (PRR 602.2).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Niraparib | 36 | 602.2 | 603.2 |
| Anti-Thymocyte Globulin (Rabbit) | 5 | 148.2 | 148.3 |